Literature DB >> 26094952

Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.

N Valiño1, G Giunta1, D M Gallo1, R Akolekar1,2, K H Nicolaides1.   

Abstract

OBJECTIVE: To investigate the potential value of biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
METHODS: This was a screening study in 8268 singleton pregnancies at 30-34 weeks' gestation. Estimated fetal weight (EFW), uterine artery (UtA) pulsatility index (PI), umbilical artery (UA) PI, fetal middle cerebral artery (MCA) PI, mean arterial pressure (MAP), serum placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) were measured. The detection rate (DR) and false-positive rate (FPR) of screening by each biomarker were estimated for stillbirth, pre-eclampsia, delivery of small-for-gestational-age (SGA) neonate, Cesarean section for fetal distress before or during labor, umbilical arterial cord blood pH ≤7.0 or umbilical venous cord blood pH ≤7.1, 5-min Apgar score < 7 and admission to the neonatal unit (NNU).
RESULTS: Multivariable regression analysis demonstrated that significant prediction of PE was provided by PlGF, sFlt-1, MAP and MCA-PI, with a DR of 98% for PE delivering < 37 weeks' gestation and 56% for those delivering ≥ 37 weeks, at a 10% FPR. Prediction of SGA was provided by EFW, PlGF, sFlt-1, UtA-PI, UA-PI and MCA-PI, with a DR of 88% for SGA delivering < 37 and 51% for those delivering ≥ 37 weeks' gestation, at a 10% FPR. Prediction of stillbirth was provided by EFW, UtA-PI and MCA-PI, with DR of 30% at 10% FPR. Prediction of Cesarean section for fetal distress before labor was provided by EFW, sFlt-1, UtA-PI and UA-PI, with a DR of 90% at a 10% FPR. Prediction of fetal distress in labor was provided by EFW and sFlt-1, with a DR of 16% at a 10% FPR. There were no significant differences from the normal outcome group in any of the biomarkers for low cord blood pH, low Apgar score or NNU admission for cases other than those with PE and/or SGA.
CONCLUSION: At 30-34 weeks' gestation, biomarkers of impaired placentation and fetal hypoxemia provide good prediction of PE, SGA and fetal distress before labor, but poor or no prediction of stillbirth and adverse events in labor or after birth.
Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  mean arterial pressure; middle cerebral artery Doppler; perinatal outcome; placental growth factor; pyramid of antenatal care; sFlt-1; third-trimester screening; umbilical artery Doppler; uterine artery Doppler

Mesh:

Substances:

Year:  2016        PMID: 26094952     DOI: 10.1002/uog.14928

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  11 in total

1.  Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis.

Authors:  Gordon Cs Smith; Alexandros A Moraitis; David Wastlund; Jim G Thornton; Aris Papageorghiou; Julia Sanders; Alexander Ep Heazell; Stephen C Robson; Ulla Sovio; Peter Brocklehurst; Edward Cf Wilson
Journal:  Health Technol Assess       Date:  2021-02       Impact factor: 4.014

2.  Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.

Authors:  Nuria Martínez-Sánchez; Sergio Pérez-Pinto; Ángel Robles-Marhuenda; Francisco Arnalich-Fernández; María Martín Cameán; Edurne Hueso Zalvide; Jose Luis Bartha
Journal:  Immunol Res       Date:  2017-04       Impact factor: 2.829

3.  Personalized Model to Predict Small for Gestational Age at Delivery Using Fetal Biometrics, Maternal Characteristics, and Pregnancy Biomarkers: A Retrospective Cohort Study of Births Assisted at a Spanish Hospital.

Authors:  Peña Dieste-Pérez; Ricardo Savirón-Cornudella; Mauricio Tajada-Duaso; Faustino R Pérez-López; Sergio Castán-Mateo; Gerardo Sanz; Luis Mariano Esteban
Journal:  J Pers Med       Date:  2022-05-08

4.  Reference Centile Chart of Fetal Cerebroplacental Doppler from 24 to 40 Weeks Gestation in Indian Population.

Authors:  Tarul Umarwal; Manisha Kumar
Journal:  J Obstet Gynaecol India       Date:  2019-05-21

5.  A possible new approach in the prediction of late gestational hypertension: The role of the fetal aortic intima-media thickness.

Authors:  Silvia Visentin; Ambrogio P Londero; Martina Camerin; Enrico Grisan; Erich Cosmi
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

6.  Utility of Doppler parameters at 36-42 weeks' gestation in the prediction of adverse perinatal outcomes in appropriate-for-gestational-age fetuses.

Authors:  Michał Migda; Katarzyna Gieryn; Bartosz Migda; Marian Stanisław Migda; Marek Maleńczyk
Journal:  J Ultrason       Date:  2018-03-30

7.  Sex differences in uterine artery Doppler during gestation in pregnancies complicated by placental dysfunction.

Authors:  Leah Paranavitana; Melissa Walker; Anjana Ravi Chandran; Natasha Milligan; Shiri Shinar; Clare L Whitehead; Sebastian R Hobson; Lena Serghides; W Tony Parks; Ahmet A Baschat; Christopher K Macgowan; John G Sled; John C Kingdom; Lindsay S Cahill
Journal:  Biol Sex Differ       Date:  2021-02-02       Impact factor: 5.027

8.  Placental growth factor level is correlated with intrapartum fetal heart rate findings.

Authors:  Hiroaki Tanaka; Kayo Tanaka; Sho Takakura; Naosuke Enomoto; Shintaro Maki; Tomoaki Ikeda
Journal:  BMC Pregnancy Childbirth       Date:  2022-03-17       Impact factor: 3.007

9.  The ability of late pregnancy maternal tests to predict adverse pregnancy outcomes associated with placental dysfunction (specifically fetal growth restriction and pre-eclampsia): a protocol for a systematic review and meta-analysis of prognostic accuracy studies.

Authors:  Melanie Griffin; Alexander E P Heazell; Lucy C Chappell; Jian Zhao; Deborah A Lawlor
Journal:  Syst Rev       Date:  2020-04-08

10.  Bemiparin as a Prophylaxis After an Unexplained Stillbirth: Open-Label Interventional Prospective Study.

Authors:  Ariana Khalis Jawad; Shahla Kareem Alalaf; Mahabad Salih Ali; AbdulKader Ahmad Bawadikji
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.